The FRAIL-FIT 30 Study - Factors influencing 30-day mortality in frail patients admitted to ICU: A retrospective observational cohort study.
Clinical Frailty Scale
Frailty
intensive care
mortality
Journal
Journal of the Intensive Care Society
ISSN: 1751-1437
Titre abrégé: J Intensive Care Soc
Pays: England
ID NLM: 101538668
Informations de publication
Date de publication:
May 2022
May 2022
Historique:
entrez:
26
5
2022
pubmed:
27
5
2022
medline:
27
5
2022
Statut:
ppublish
Résumé
Frailty is a multi-dimensional syndrome of reduced reserve, resulting from overlapping physiological decrements across multiple systems. The contributing factors, temporality and magnitude of frailty's effect on mortality after ICU admission are unclear. This study assessed frailty's impact on mortality and life sustaining therapy (LST) use, following ICU admission. This single-centre retrospective observational cohort study analysed data collected prospectively in Glasgow Royal Infirmary ICU. Of 684 eligible patients, 171 were frail and 513 were non-frail. Frailty was quantified using the Rockwood Clinical Frailty Scale (CFS). All patients were followed up 1-year after ICU admission. The primary outcome was all-cause mortality at 30-days post-ICU admission. Key secondary outcomes included mortality at 1-year and LST use. Frail patients were significantly less likely to survive 30-days post-ICU admission (61.4% vs 81.1%, p < 0.001). This continued to 1-year (48.5% vs 68.2%, p < 0.001). Frailty significantly increased mortality hazards in covariate-adjusted analyses at 30-days (HR 1.56; 95%CI 1.14-2.15; p = 0.006), and 1-year (HR 1.35; 95%CI 1.03-1.76; p = 0.028). Single-point CFS increases were associated with a 30-day mortality hazard of 1.23 (95%CI 1.13-1.34; p < 0.001) in unadjusted analyses, and 1.11 (95%CI 1.01-1.22; p = 0.026) after covariate adjustment. Frail patients received significantly more days of LST (median[IQR]: 5[3,11] vs 4[2,9], p = 0.008). Frailty was significantly associated with greater mortality at all time points studied, but most notably in the first 30-days post-ICU admission. This was despite greater LST use. The accrual effect of frailty increased adverse outcomes. Point-by-point use of frailty scoring could allow for more informed decision making in ICU.
Sections du résumé
Background
UNASSIGNED
Frailty is a multi-dimensional syndrome of reduced reserve, resulting from overlapping physiological decrements across multiple systems. The contributing factors, temporality and magnitude of frailty's effect on mortality after ICU admission are unclear. This study assessed frailty's impact on mortality and life sustaining therapy (LST) use, following ICU admission.
Methods
UNASSIGNED
This single-centre retrospective observational cohort study analysed data collected prospectively in Glasgow Royal Infirmary ICU. Of 684 eligible patients, 171 were frail and 513 were non-frail. Frailty was quantified using the Rockwood Clinical Frailty Scale (CFS). All patients were followed up 1-year after ICU admission. The primary outcome was all-cause mortality at 30-days post-ICU admission. Key secondary outcomes included mortality at 1-year and LST use.
Results
UNASSIGNED
Frail patients were significantly less likely to survive 30-days post-ICU admission (61.4% vs 81.1%, p < 0.001). This continued to 1-year (48.5% vs 68.2%, p < 0.001). Frailty significantly increased mortality hazards in covariate-adjusted analyses at 30-days (HR 1.56; 95%CI 1.14-2.15; p = 0.006), and 1-year (HR 1.35; 95%CI 1.03-1.76; p = 0.028). Single-point CFS increases were associated with a 30-day mortality hazard of 1.23 (95%CI 1.13-1.34; p < 0.001) in unadjusted analyses, and 1.11 (95%CI 1.01-1.22; p = 0.026) after covariate adjustment. Frail patients received significantly more days of LST (median[IQR]: 5[3,11] vs 4[2,9], p = 0.008).
Conclusion
UNASSIGNED
Frailty was significantly associated with greater mortality at all time points studied, but most notably in the first 30-days post-ICU admission. This was despite greater LST use. The accrual effect of frailty increased adverse outcomes. Point-by-point use of frailty scoring could allow for more informed decision making in ICU.
Identifiants
pubmed: 35615231
doi: 10.1177/1751143720985164
pii: 10.1177_1751143720985164
pmc: PMC9125452
doi:
Types de publication
Journal Article
Langues
eng
Pagination
150-161Informations de copyright
© The Intensive Care Society 2021.
Déclaration de conflit d'intérêts
Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Références
CMAJ. 2014 Feb 4;186(2):E95-102
pubmed: 24277703
Aging Clin Exp Res. 2017 Apr;29(2):247-255
pubmed: 27002968
J Crit Care. 2014 Jun;29(3):401-8
pubmed: 24559575
CMAJ. 2005 Aug 30;173(5):489-95
pubmed: 16129869
Anaesthesia. 2007 Nov;62(11):1095-100
pubmed: 17924888
Crit Care. 2011;15(1):301
pubmed: 21345259
Am J Respir Crit Care Med. 2017 Jul 1;196(1):64-72
pubmed: 27922747
Crit Care Med. 1985 Oct;13(10):818-29
pubmed: 3928249
Intensive Care Med. 2017 Dec;43(12):1887-1888
pubmed: 29085974
J Am Geriatr Soc. 2005 Jan;53(1):88-93
pubmed: 15667382
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
pubmed: 11253156
Crit Care. 2009;13(2):R45
pubmed: 19335921
Intensive Care Med. 2014 May;40(5):674-82
pubmed: 24651884
JAMA. 1993 Dec 22-29;270(24):2957-63
pubmed: 8254858
Ann Transl Med. 2017 Dec;5(Suppl 4):S38
pubmed: 29302594
J Gerontol A Biol Sci Med Sci. 2015 Dec;70(12):1586-94
pubmed: 26400736
Crit Care. 2016 Jun 06;20(1):175
pubmed: 27263535
Intensive Care Med. 2018 Sep;44(9):1512-1520
pubmed: 30105600
J Intensive Care Soc. 2020 May;21(2):124-133
pubmed: 32489408
Clin Med (Lond). 2010 Jun;10(3):282-5
pubmed: 20726464
Ann Intensive Care. 2011 Aug 01;1(1):29
pubmed: 21906383
Crit Care Med. 2015 Jul;43(7):1352-60
pubmed: 25901550
J Gerontol A Biol Sci Med Sci. 2004 Mar;59(3):255-63
pubmed: 15031310
Intensive Care Med. 2017 Aug;43(8):1105-1122
pubmed: 28676896
Crit Care. 2018 Feb 26;22(1):49
pubmed: 29478414
Intensive Care Med. 2018 Jul;44(7):1027-1038
pubmed: 29774388
Intensive Care Med. 2018 Nov;44(11):1926-1928
pubmed: 29356853
Intensive Care Med. 2017 Dec;43(12):1820-1828
pubmed: 28936626
Z Gerontol Geriatr. 1999 Jun;32(3):193-9
pubmed: 10436499
BMC Geriatr. 2017 Jan 21;17(1):28
pubmed: 28107813
CMAJ. 2011 May 17;183(8):E487-94
pubmed: 21540166
PLoS One. 2012;7(4):e34387
pubmed: 22509296
JAAPA. 2016 Apr;29(4):34-7
pubmed: 27023654
Ann Surg. 2016 Dec;264(6):1116-1124
pubmed: 26655919
JAMA. 2001 Oct 10;286(14):1754-8
pubmed: 11594901
Intensive Care Med. 2007 Jul;33(7):1252
pubmed: 17404703
Intensive Care Med. 2018 Aug;44(8):1221-1229
pubmed: 29968013